Evidence map›Paper›PMID 22823477›Full record

Trial reportDiabetic medicine : a journal of the British Diabetic Association2012

Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial.

R K Simmons, S J Sharp, A Sandbæk, K Borch-Johnsen, M J Davies, K Khunti, T Lauritzen, G E H M Rutten, M van den Donk, N J Wareham and 1 more

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Diabetic medicine : a journal of the British Diabetic Association, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Screening for type 2 diabetes mellitus.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

R K SimmonsMRC Epidemiology Unit, Cambridge, UK. rebecca.simmons@mrc-epid.cam.ac.uk
S J Sharp
A Sandbæk
K Borch-Johnsen
M J Davies
K Khunti
T Lauritzen
G E H M Rutten
M van den Donk
N J Wareham
S J Griffin
MRC Epidemiology Unit · GBAarhus University Hospital · DKUniversity Medical Center Utrecht · NLUniversity of Leicester · GBUniversity of Southern Denmark · DK

Funding

Department of Health 08/116/300Department of Health RP-DG-1210-10183Department of Health RP-PG-0606-1259Department of Health RP-PG-0606-1272Medical Research Council G0001164Medical Research Council MC_U106179471Medical Research Council MC_U106179474Wellcome TrustWellcome Trust G061895
6 · The paper itself

Abstract

aimsTo describe the total cardiovascular burden (cardiovascular morbidity or mortality, revascularization or non-traumatic amputation) in individuals with screen-detected diabetes in the ADDITION-Europe trial and to quantify the impact of the intervention on multiple cardiovascular events over 5 years.

methodsIn a pragmatic, cluster-randomized, parallel-group trial in four centres (Denmark; Cambridge, UK; the Netherlands; and Leicester, UK), 343 general practices were randomized to screening plus routine care (n = 1379 patients), or screening and promotion of target-driven, intensive treatment of multiple risk factors (n = 1678). We estimated the effect of the intervention on multiple cardiovascular events after diagnosis of diabetes using the Wei, Lin and Weissfeld method.

resultsOver 5.3 years, 167 individuals had exactly one cardiovascular event, 53 exactly two events, and 18 three or more events. The incidence rates (95% CI) of first events and any event per 1000 person-years were 14.6 (12.8-16.6) and 20.4 (18.2-22.6), respectively. There were non-significant reductions in the risk of a first (hazard ratio 0.83, 95% CI 0.65-1.05) and second primary endpoint (hazard ratio 0.70, 95% CI 0.43-1.12). The overall average hazard ratio for any event was 0.77 (95% CI 0.58-1.02).

conclusionsEarly intensive multifactorial treatment was not associated with a significant reduction in total cardiovascular burden at 5 years. Focusing on first events in cardiovascular disease prevention trials underestimates the total cardiovascular burden to patients and the health service.

Indexed as

AdultAgedAmputation, SurgicalCardiovascular DiseasesCluster AnalysisDenmarkDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleGlycated HemoglobinHumansMaleMass ScreeningMiddle AgedNetherlandsRisk FactorsGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID22823477
PMCPMC3698698
OpenAlexW1521253260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.